News

Excalipoint Therapeutics has secured an oversubscribed $68.7 million seed financing round to accelerate the development of its next-generation T-cell engager (TCE) therapies, marking…
Read More...

The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) have unveiled a new collaborative framework aimed at speeding…
Read More...

Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an investigational oral therapy designed to treat hormone receptor-positive,…
Read More...

Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), a novel oral therapy for the treatment of moderate-to-severe…
Read More...

Voro Therapeutics has entered into a research collaboration with Daiichi Sankyo to develop next-generation antibody-drug conjugates (ADCs) using its proprietary PrimeBody platform. The…
Read More...

Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio Therapeutics Inc. to advance the manufacturing of regulatory T-cell (Treg)…
Read More...

R1 Therapeutics has officially launched as a new clinical-stage biopharmaceutical company, backed by an oversubscribed $77.5 million Series A financing and a strategic licensing…
Read More...

Sun Pharmaceutical Industries Limited has announced that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental Biologics License Application (sBLA) for…
Read More...

Aldeyra Therapeutics has received a setback in its efforts to bring a new treatment for dry eye disease to market, following a Complete Response Letter (CRL) issued by the U.S. Food and…
Read More...

Roche has announced a major expansion of its global artificial intelligence (AI) infrastructure, unveiling a large-scale “AI factory” powered by next-generation accelerated computing…
Read More...

Sentynl Therapeutics, a U.S.-based biopharmaceutical company and a wholly owned subsidiary of Zydus Lifesciences, has entered into a licensing agreement with South Korea-based PRG…
Read More...

Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of pediatric patients aged 12 years and older with moderate…
Read More...

GSK plc has announced that the U.S. Food and Drug Administration (FDA) has expanded the approved use of its respiratory syncytial virus (RSV) vaccine, Arexvy, to include adults aged 18…
Read More...

Akeso, Inc. has announced that its novel trispecific antibody candidate, AK150, has received Investigational New Drug (IND) clearance from the National Medical Products Administration…
Read More...

Earendil Labs has entered into a strategic collaboration with WuXi Biologics to accelerate the development and manufacturing of a portfolio of next-generation biologics, including…
Read More...

GelMEDIX Inc. and Catalent, Inc. have announced a global partnership aimed at advancing regenerative therapies designed to restore vision in patients with ocular and retinal diseases.…
Read More...

Johnson & Johnson has received approval from the U.S. Food and Drug Administration for its TECNIS PureSee intraocular lens (IOL), a new extended depth of focus (EDOF) lens designed…
Read More...

Vima Therapeutics has announced significant progress in the development of its experimental treatment for movement disorders, revealing that the first patient has been dosed in a Phase…
Read More...

PsiQuantum has announced a new collaborative research agreement with National Cancer Center Japan aimed at advancing the use of utility-scale quantum computing in oncology and…
Read More...

Eli Lilly and Company has issued a public warning about potential safety risks linked to compounded versions of tirzepatide that are being mixed with vitamin B12 and marketed to…
Read More...